| Alternative strategies for the management of respiratory failure in the newborn--clinical realities. | |
| | |
MedLine Citation:
|
PMID: 12464505 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Following the introduction of surfactant in the early 1990s and the growing use of antenatal steroids since that time, the number of infants, term and preterm, suffering severe acute respiratory failure has declined. However, such babies do still occur and their management causes much debate and concern not least because of the recognised high risk of adverse outcome in these babies. This article reviews the therapeutic options available when other more routine strategies fail. |
| | |
Authors:
|
David Field |
Related Documents
:
|
10996275 - Postnatal weight loss and contraction of the extracellular compartment is triggered by ... 23522865 - Indomethacin prophylaxis to prevent intraventricular hemorrhage: association between in... 8233735 - Comparison of prophylaxis and rescue treatment with curosurf in neonates less than 30 w... 2458035 - Neurodevelopmental and respiratory outcome in early childhood after human surfactant tr... 12285845 - Fertility estimates of bangladesh using 1974 and 1981 census data. 8579655 - Congenital genitourinary tract abnormalities following cocaine exposure in utero. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Seminars in neonatology : SN Volume: 7 ISSN: 1084-2756 ISO Abbreviation: Semin Neonatol Publication Date: 2002 Oct |
Date Detail:
|
Created Date: 2002-12-04 Completed Date: 2003-03-20 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 9606001 Medline TA: Semin Neonatol Country: England |
Other Details:
|
Languages: eng Pagination: 429-36 Citation Subset: IM |
Affiliation:
|
Department of Child Health, Robert Kilpatrick Clinical Sciences Building, University of Leicester, Leicester LE2 7LX, UK. david.field@uhl-tr.nhs.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Bronchodilator Agents / therapeutic use* Clinical Competence Combined Modality Therapy Extracorporeal Membrane Oxygenation / methods* High-Frequency Ventilation / methods* Humans Infant, Newborn Intensive Care, Neonatal Liquid Ventilation / methods* Nitric Oxide / therapeutic use* Quality Assurance, Health Care Randomized Controlled Trials as Topic Respiratory Distress Syndrome, Newborn / therapy* United States |
| Chemical | |
Reg. No./Substance:
|
0/Bronchodilator Agents; 10102-43-9/Nitric Oxide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Weaning newborns from mechanical ventilation.
Next Document: Surgical versus medical treatment for severe epilepsy: consequences for intellectual functioning in ...